United Orthopedic (4129) Fundamentals 2026 — P/E 19.3x, Revenue Analysis | SniperIQ
United Orthopedic (4129) is a TW-listed Healthcare company in Medical - Devices with a market capitalization of NT$8.8B, trading at NT$91.70 on the TWO. This SniperIQ fundamentals page covers United Orthopedic's valuation (P/E 19.3x, P/B 2.1x), profitability (net margin 7.9%), revenue (NT$5.7B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is United Orthopedic's market cap?
United Orthopedic (4129) has a market capitalization of approximately NT$8.8B, trading at NT$91.70 on the TWO. Market cap moves with the live share price.
What is United Orthopedic's P/E ratio?
United Orthopedic's trailing twelve-month P/E ratio is 19.3x, with a price-to-book (P/B) of 2.1x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is United Orthopedic?
United Orthopedic runs a net profit margin of 7.9%, a gross margin of 77.6%, and an operating margin of 11.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does United Orthopedic generate?
United Orthopedic reported revenue of NT$5.7B for fiscal year 2025, with net income of NT$562M and earnings per share (EPS) of 5.83. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does United Orthopedic pay a dividend?
United Orthopedic offers a trailing dividend yield of about 4.4%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is United Orthopedic financially healthy?
United Orthopedic carries a debt-to-equity ratio of 0.54x and a current ratio of 1.66x, with a market beta of 0.36. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is United Orthopedic a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For United Orthopedic (4129) the key facts are: market cap NT$8.8B, P/E 19.3x, revenue NT$5.7B, 52-week range 86.8-131.5. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track United Orthopedic's full fundamentals live
Get United Orthopedic's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.